petmeds® is america's largest pet pharmacy, a publicly traded company (nasdaq: pets). we deliver prescription and non-prescription pet meds along with health and nutritional supplements for dogs, cats and horses at substantial savings directly to you. we serve millions of satisfied customers nationwide from one location.
![Petmed Express logo](/files/LOGO/1040130-PETS.png)
Company profile
Ticker
PETS
Exchange
Website
CEO
Menderes Akdag
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Southeastern Veterinary Exports, Inc. • Global Veterinary Supply, Inc. • 420 South Congress Avenue, LLC • PetCareRx, Inc. • PetMeds Insurance Services, LLC • Congress Park South Owners Association, Inc. • A not-for-profit corporation; 420 South Congress Avenue, LLC ...
IRS number
650680967
PETS stock data
Latest filings (excl ownership)
DEFA14A
Additional proxy soliciting materials
2 Jul 24
DEFA14A
Additional proxy soliciting materials
24 Jun 24
DEF 14A
Definitive proxy
24 Jun 24
8-K
PetMed Express, Inc. Announces Appointment of Leah Solivan to Board of Directors
24 Jun 24
10-K
2024 FY
Annual report
14 Jun 24
8-K
PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results
11 Jun 24
8-K
Departure of Directors or Certain Officers
31 May 24
8-K
PetMed Express, Inc. Announces Appointment of Justin Mennen to Board of Directors
20 May 24
8-K
PetMed Express, Inc. Names Sandra Campos as new Chief Executive Officer and President
29 Apr 24
8-K
Results of Operations and Financial Condition
15 Apr 24
Transcripts
PETS
Earnings call transcript
2024 Q4
11 Jun 24
PETS
Earnings call transcript
2024 Q3
8 Feb 24
PETS
Earnings call transcript
2024 Q2
30 Oct 23
PETS
Earnings call transcript
2024 Q1
1 Aug 23
PETS
Earnings call transcript
2024 Q1
31 Jul 23
PETS
Earnings call transcript
2023 Q4
22 May 23
PETS
Earnings call transcript
2023 Q3
6 Feb 23
PETS
Earnings call transcript
2022 Q2
8 Nov 22
PETS
Earnings call transcript
2022 Q1
26 Jul 22
PETS
Earnings call transcript
2021 Q4
10 May 22
Latest ownership filings
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 55.30 mm | 55.30 mm | 55.30 mm | 55.30 mm | 55.30 mm | 55.30 mm |
Cash burn (monthly) | (no burn) | 4.07 mm | 1.28 mm | 646.42 k | (no burn) | (no burn) |
Cash used (since last report) | n/a | 15.72 mm | 4.94 mm | 2.50 mm | n/a | n/a |
Cash remaining | n/a | 39.58 mm | 50.35 mm | 52.80 mm | n/a | n/a |
Runway (months of cash) | n/a | 9.7 | 39.4 | 81.7 | n/a | n/a |
Institutional ownership, Q1 2024
71.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 112 |
Opened positions | 46 |
Closed positions | 24 |
Increased positions | 21 |
Reduced positions | 34 |
13F shares | Current |
---|---|
Total value | 68.06 bn |
Total shares | 14.76 mm |
Total puts | 85.50 k |
Total calls | 74.90 k |
Total put/call ratio | 1.1 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 1.74 mm | $8.35 bn |
Renaissance Technologies | 1.58 mm | $7.58 mm |
Vanguard | 1.19 mm | $5.68 bn |
Hotchkis & Wiley Capital Management | 1.06 mm | $5.06 bn |
Mirae Asset Global Investments | 700.92 k | $11.48 bn |
Aqr Capital Management | 683.03 k | $3.27 bn |
Arrowstreet Capital, Limited Partnership | 563.89 k | $2.70 mm |
MNGPF Man | 547.00 k | $2.62 bn |
MS Morgan Stanley | 531.94 k | $2.55 bn |
Geode Capital Management | 483.35 k | $2.32 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Jul 24 | Leah Solivan | Common Stock | Grant | Acquire A | No | No | 0 | 943 | 0.00 | 943 |
3 Jun 24 | Mennen Justin L. | Common Stock | Grant | Acquire A | No | No | 0 | 1,373 | 0.00 | 1,373 |
31 May 24 | Christine Chambers | Common Stock | Sale back to company | Dispose D | No | No | 0 | 41,342 | 0.00 | 65,146 |
31 May 24 | Christine Chambers | Performance Share Units Common Stock | Sale back to company | Dispose D | No | No | 0 | 8,000 | 0.00 | 0 |
News
Ryan Cohen The GOAT? Fresh Data Shows Chewy Mastermind Anticipated Massive Trends In Pet Supplies
12 Jul 24
Lake Street Maintains Buy on PetMed Express, Lowers Price Target to $7
12 Jun 24
Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
12 Jun 24
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
12 Jun 24
Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $3.5
12 Jun 24
Press releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
15 Jun 24
PetMed Express, Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
14 Jun 24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
14 Jun 24
PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results
11 Jun 24
PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2024 Earnings Call
22 May 24